Florian Heitz

机构：Helios Dr. Horst Schmidt Kliniken Wiesbaden, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Kliniken Essen-Mitte, Freie Universität Berlin, Charité - Universitätsmedizin Berlin · ORCID：0000-0002-2412-0352

发表论文 593 篇 · 总被引 11120 次 · h-index 55

代表论文

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer (2025 · Annals of Oncology · 被引 21)
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial (2025 · Journal of Clinical Oncology · 被引 12)
A randomized phase II trial of mirvetuximab soravtansine in folate receptor alpha (FRα)–high recurrent ovarian cancer eligible for platinum-based chemotherapy (MIROVA/AGO-OVAR 2.34). (2026 · Journal of Clinical Oncology · 被引 4)
Final Results From the ATALANTE/ENGOT-ov29 Randomized Phase III Trial of Atezolizumab, Bevacizumab, and Platinum-Based Therapy for Late-Relapsing Recurrent Ovarian Cancer (2026 · JCO oncology advances. · 被引 1)
Primary analysis of pembrolizumab combined with chemotherapy in platinum-sensitive recurrent low-grade serous ovarian cancer: The NOGGO PERCEPTION phase II study. (2026 · Journal of Clinical Oncology · 被引 1)
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases (2026 · Cell Reports Medicine)